As explained by Peter Salgo, MD, and Yehuda Handelsman, MD, FACP, FACE, FNLA, the obesity guideline published in 2013 doesn’t offer pharmacotherapy treatment options. However, Dr Salgo cites efficacy data that support their use for weight loss.
Dr Salgo explores short- and long-term agents, many of which are now being used as combination therapy, and asks the panelists to discuss their approaches when treating patients with obesity.
Kari Uusinarkaus, MD, FAAFP, FNLA, explains that although pharmacotherapeutic agents are helpful adjuncts in the management of weight loss, not all patients respond to treatment. Dr Uusinarkaus adds that overcoming other treatment barriers still deserves attention.
Dr Handelsman and Jeffrey D. Dunn, PharmD, MBA, emphasize how cost and reimbursement issues with these agents will continue to challenge their overall success. Dr Dunn explains that because more treatment options are becoming available, a coordinated effort to provide coverage is necessary.
Dr Handelsman emphasizes that, although there are effective pharmacotherapeutic options, lifestyle modification remains important. Dr Handelsman explains that not all patients who are obese require medication. Patients with complications should consider pharmacotherapeutic agents in combination with lifestyle interventions. For this reason, physicians need to focus on each patient as an individual when making treatment decisions.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More